C12Y 204/01224
Glucuronosyl-n-acetylglucosaminyl-proteoglycan 4-alpha-n-acetylglucosaminyltransferase
Official title: Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase (2.4.1.224)
C12Y204/01224 (Glucuronosyl-n-acetylglucosaminyl-proteoglycan 4-alpha-n-acetylglucosaminyltransferase) appears on 1 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 4
- Assignees
- 4
- Inventors
- 12
- Latest grant
- 6 Jul 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
By publication year.
Recent patents
- Anticoagulant heparin-chondroitin chimeric saccharide molecule as well as preparation method and application thereof12 Jun 2025US 2025/0188506 A1Shandong University
- Heparin sulfate biosynthesis pathway enzyme irna agent compositions and methods of use thereof13 Mar 2025US 2025/0084417 A1Alnylam Pharmaceuticals, Inc.
- Depletion of ext1 expression and/or activity improves cellular production of biological entities1 Jun 2023US 2023/0167449 A1Universite De Liege
- Methods of treating neurodegenerative disease by inhibiting n-deacetylase n-sulfotransferase4 Jun 2020US 2020/0172910 A1The Penn State Research Foundation
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.